Early in the history of MR technology, engineers looked into and then abandoned the development of superconducting surface coils. Now interest in this approach has come full circle with the Q-coil, a superconducting platform designed for high-field imaging.
Early in the history of MR technology, engineers looked into and then abandoned the development of superconducting surface coils. Now interest in this approach has come full circle with the Q-coil, a superconducting platform designed for high-field imaging.
Prototypes produced by Columbia University spin-off Supertron Technologies have begun human subject testing. The CEO of the Newark, NJ, company, C. Richard Hullihen, plans to begin commercializing the technology in 2007 through a mix of OEM and direct sales.
"We may end up doing some contract manufacturing for folks that have a very special need or interest, but other than that we see ourselves going directly to end users," said Hullihen, a 30-year-plus veteran of the imaging industry.
Surface coils cooled by liquid nitrogen have the potential to boost signal. Preliminary tests of the start-up's Q-Coil on a GE 0.2T Profile scanner increased image quality by 300% or reduced scan time by a factor of 600%. Use of the technology at Brigham and Women's Hospital delivered an image of the eye at 0.2T comparable to one achieved at 1.5T.
While low-field imaging proved the potential of this approach, this is not where the company is focusing its efforts. Prototypes now in testing are designed for 1.5T clinical applications and 3T animal studies.
The technology, developed at Columbia University, is covered by seven issued and five pending patents. State and federal grants funded early work, and ongoing development is being aided by a round of private financing closed late last year.
The financial viability of the technology increased with the recent change in direction toward 32-, 64-, and 128-channel coils, according to Hullihen. The development of these megachannel machines has made the use of supercooled surface coils attractive.
"These scanners are built for the use of very small field-of-view coils assembled into arrays, and that comes right back to what we are doing," he said. "The benefits suddenly become relevant."
As coil FOV shrinks, noise from the coil and the associated electronics becomes a dominant source of the overall signal-to-noise ratio, Hullihen said. Supercooling the technology addresses this problem.
"Noise drops as you cool the coil," he said.
First in line for commercialization is a head coil. Future coils will be designed to support emerging applications, according to Hullihen.
Their design must figure in the special needs that accompany superconducting technology - a vacuum and the circulation of liquid nitrogen around the coils. But the coils Hullihen has in mind will look and operate much like conventional surface coils.
"If a user has to do anything special, then we didn't finish the development task," he said. "We want to make how we do this invisible."
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.